- FTC Sends Warning Letters to Multi-Level Marketers Regarding Health and Earnings Claims They or Their Participants are Making Related to Coronavirus ( )
- FTC Sends 21 Letters Warning Marketers to Stop Making Unsupported Claims That Their Products and Therapies Can Effectively Treat Coronavirus ( )
- FTC Takes Action to Stop Direct Mail Pill Marketers’ Unproven Health Claims ( )
- FTC Halts Bogus Claims about “Miracle” Supplement for Older Adults ( )
- FTC Announces Latest Round of Letters Warning Companies to Cease Unsupported Claims that Their Products Can Treat or Prevent Coronavirus ( )
- FTC Warns Nine VoIP Service Providers and Other Companies against ‘Assisting and Facilitating’ Illegal Coronavirus-related Telemarketing Calls ( )
- FTC Chairman Joe Simons Outlines the Agency’s Approach to Safeguarding Consumers during the Coronavirus Pandemic ( )
- Federal Trade Commission and Justice Department Announce Expedited Antitrust Procedure and Guidance for Coronavirus Public Health Efforts ( )
- FTC, FDA Send Warning Letters to Seven Companies about Unsupported Claims that Products Can Treat or Prevent Coronavirus ( )
- Tea Marketer Misled Consumers, Didn’t Adequately Disclose Payments to Well-Known Influencers, FTC Alleges ( )
- FTC Refunding Consumers Defrauded by Cognitive Improvement Claims ( )
- FTC Takes Action to Stop Anti-Aging “Cure-All” Marketers From Making Baseless Health Claims ( )
- FTC, State of Maine File Contempt Action against Dietary Supplement Marketers ( )
- FTC Sending Additional Refund Checks to Consumers Who Bought LeanSpa Products ( )
- FTC Stops Marketers from Making False Arthritis Treatment Claims ( )
- FTC Sending Refund Checks Totaling Over $1.8 Million to Consumers Defrauded by “Risk-Free” Trial Offers for Skin Care Products ( )
- FTC Sues Publisher for Targeting Seniors With Phony Diabetes Cure and Money Making Schemes ( )
- FTC and FDA Warn Florida Company Marketing CBD Products about Claims Related to Treating Autism, ADHD, Parkinson’s, Alzheimer’s, and Other Medical Conditions ( )
- Aloe Vera Supplement Seller Barred from Making Misleading Health Claims ( )
- FTC Flags Potentially Unlawful TV Ads for Prescription Drug Lawsuits ( )
- FTC Sends Warning Letters to Companies Advertising Their CBD-Infused Products as Treatments for Serious Diseases, Including Cancer, Alzheimer’s, and Multiple Sclerosis ( )
- FTC Obtains Preliminary Injunction Halting Online Beauty Product Sellers’ Deceptive “Free Trial” Offers ( )
- FTC Refunds Consumers Who Bought FlexiPrin Joint Pain Supplement ( )
- FTC Refunds Consumers Who Bought Deceptively Marketed and Advertised “Nobetes” Diabetes Treatment Supplement ( )
- FTC Approves Stipulated Order Settling Charges against Gerber Products Company ( )
- Consumers Still Paying for Sham Insurance Products Sold by Simple Health to be Notified About the Fraud and Provided an Opportunity to Enroll in Comprehensive Health Insurance Plans During a Special Enrollment Period ( )
- FTC and Law Enforcement Partners to Announce Robocall Enforcement Sweep Tomorrow in Chicago ( )
- La FTC y otras agencias a cargo del cumplimiento de la ley anuncian mañana en Chicago un enérgico operativo de cumplimento de la ley ( )
- FTC and FDA Send Warning Letters to Companies Selling Flavored E-liquids About Social Media Endorsements without Health Warnings ( )
- Online Marketers Barred from Deceptive “Free Trial” Offers, Unauthorized Billing ( )